Science.Online
Publisher and Institutes
Akademie Verlag
Deutsches Institut für Urbanistik
Oldenbourg Wissenschaftsverlag
Walter de Gruyter
Schattauer
You are here: Home :: Keyword index :: gen bis Hyd :: hepatitis C virus infection - Herz-Kreislauf-Erkrankungen Hepatocellular carcinoma

Items for "Hepatocellular carcinoma"

Direct injection of 188Re-microspheres in the treatment of hepatocellular carcinoma: Compared with traditional percutaneous ethanol injection: an animal study

The aim of this study was to compare the therapeutic efficacies of direct intratumoural injection of 188Re microspheres (DIRM) and direct intratumoural injection of ethanol (DIE) in rabbits bearing liver tumours...

Keywords: Leberzellkarzinom, 188Re-Mikrosphären, Ethanolinjektion

01/2005 | Nuklearmedizin, Schattauer
Therapy of hepatocellular carcinoma with iodine-131-lipiodol. Results in a large German cohort

AIM: To evaluate the efficacy and tolerance of iodine-131-lipiodol (131I-lipiodol) for hepatocellular carcinoma (HCC) in German long term patients and comparison with medically treated controls...

Keywords: Hepatozelluläres Karzinom, Tumortherapie, Iod-131-Lipiodol, Pfortaderthrombose, Langzeitanalyse

01/2006 | Nuklearmedizin, Schattauer
New perspectives and strategy research biomarkers for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. Cirrhosis caused by hepatitis B virus, hepatitis C virus or chronic alcohol intake is associated with major risk...

Keywords: biological markers, cirrhosis, ?-fetoprotein, genomic, Hepatocellular carcinoma

09/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Evaluation of serum levels of p53 in hepatocellular carcinoma in Egypt

Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-induced death...

Keywords: ?-fetoprotein, hepatitis B virus (HBV), hepatitis C virus (HCV), Hepatocellular carcinoma, p53

05/2006 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Development of des-?-carboxy prothrombin (DCP) measuring reagent using the LiBASys clinical analyzer

Background: Des-?-carboxy prothrombin (DCP), Lens culinaris agglutinin-reactive ?-fetoprotein ratio (AFP-L3) and total ?-fetoprotein (AFP) are tumor markers useful for diagnosing and determining the prognosis of hepatocellular carcinoma (HCC)...

Keywords: des-?-carboxy-prothrombin, Hepatocellular carcinoma, Lens culinaris agglutinin-reactive ?-fetoprotein ratio (AFP-L3), LiBASys, total ?-fetoprotein (AFP)

03/2008 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Caspase-3 gene transfected with LIGHT gene: can it be used for therapy of human hepatocellular carcinoma?

Background: The aim of this study was to detect the expression of apoptosis factor caspase-3 in transferred HepG2 cells and provide feasible evaluation of the treatment for primary liver cancer with gene methods.

Methods: The pcDNA4C-LIGHT cDNA was extracted from Escherichia coli JM-109; then, the pcDNA4C-LIGHT cDNA was transferred into the HepG2 cells by a cationic liposome mediated method...

Keywords: CASPASE-3, Hepatocellular carcinoma, HepG2 cell, LIGHT gene, transfection

04/2008 | Clinical Chemical Laboratory Medicine, Walter de Gruyter
Can E-cadherin and CD34 be used as indicators of prognosis for hepatocellular carcinoma patients?

Backgroud: The high postoperative recurrence of hepatocellular carcinoma (HCC) is a problem that would benefit from the identification of indicators of recurrence and prognosis...

Keywords: E-cadherin, CD34, co-expression, Hepatocellular carcinoma, prognostic indicator

08/2008 | Clinical Chemical Laboratory Medicine, Walter de Gruyter